Quince Therapeutics
QNCX
QNCX
41 hedge funds and large institutions have $145M invested in Quince Therapeutics in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
8% more funds holding
Funds holding: 38 → 41 (+3)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
41
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$60.1M | |
| 2 | +$22M | |
| 3 | +$6.44M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.46M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$1.25M |
Top Sellers
| 1 | -$3.53M | |
| 2 | -$2.78M | |
| 3 | -$1.59M | |
| 4 |
Morgan Stanley
New York
|
-$1.01M |
| 5 |
Goldman Sachs
New York
|
-$999K |